Drug Shortage Report for INTEGRILIN
Report ID | 58622 |
Drug Identification Number | 02240352 |
Brand name | INTEGRILIN |
Common or Proper name | Eptifibatide Injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EPTIFIBATIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10ML |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-09-25 |
Actual start date | |
Estimated end date | 2018-09-28 |
Actual end date | 2018-09-24 |
Shortage status | Avoided shortage |
Updated date | 2018-09-24 |
Company comments | limited quantity available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-09-24 | English | Compare |
v4 | 2018-09-10 | French | Compare |
v3 | 2018-09-10 | English | Compare |
v2 | 2018-08-21 | French | Compare |
v1 | 2018-08-21 | English | Compare |
Showing 1 to 5 of 5